News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cinven Ltd. Buys Mercury Pharma From HgCapital for $732 Million



8/20/2012 7:21:50 AM

Investor HgCapital has sold British pharmaceutical company Mercury Pharma to private equity firm Cinven for 465 million pounds ($732 million). "The realisation of Mercury Pharma marks the continued development of HgCapital's investment focus in the healthcare sector," said HgCapital's head of healthcare, Philipp Schwalber, in a statement on Friday. "We continue to seek out businesses that enjoy niches of secular growth despite the challenges facing much of the healthcare space," he said.

Read at Reuters
Read at The Deal.com
Read at Newstatesman
Read at PharmaBiz


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES